Predictive Factors of Development of Graves’ Ophthalmopathy for Patients with Juvenile Graves’ Disease

Table 3

Comparison of initial laboratory findings between the groups at GD onset.

	GO (−)	GO (+)	value
FT4, pmol/L	32.40 (25.50–48.88)	59.19 (39.90–77.20)	<0.001
FT3, pmol/L	8.86 (6.80–14.77)	20.87 (11.57–28.80)	<0.001
TSH, mIU/L	0.01 (0.01–0.01)	0.01 (0.01–0.02)	0.162
TRAb, U/L	10.40 (4.90–22.00)	38.25 (23.58–61.43)	<0.001
AntiTPO, kU/L	68.00 (15.90–388.69)	146.00 (56.00–506.63)	0.045
AntiTg, kU/mL	92.50 (14.50–346.25)	39.30 (14.00–620.00)	0.641